200M reinforces investment in LiMM Therapeutics

9 January, 2021

News

After a first joint investment of a total amount of € 2M, in April 2019, the 200M Fund and Seventure Partners join forces again and reinforce the investment in another € 1,550M in LiMM Therapeutics, a biopharmaceutical company that develops innovative therapeutic solutions for the treatment of immune diseases.

ABOUT

A Matching Fund that aims to foster Co-investment in high growth startups in Portugal, with national or international private Co-investors.

USEFUL LINKS

CONTACT US

For more information please fill out the form below. Thank You.

We care about your personal data and it is important that the data is delivered in a free and clear way. To this extent, we invite you to take a look at our Personal Data Protection Policy.

Managed by

Partners

Co-financed by